MX4820E - Procedimiento para la preparacion de derivados de 5,6-cia y-5,6-trans-10,19-dihidro vitamina d - Google Patents

Procedimiento para la preparacion de derivados de 5,6-cia y-5,6-trans-10,19-dihidro vitamina d

Info

Publication number
MX4820E
MX4820E MX775774U MX577477U MX4820E MX 4820 E MX4820 E MX 4820E MX 775774 U MX775774 U MX 775774U MX 577477 U MX577477 U MX 577477U MX 4820 E MX4820 E MX 4820E
Authority
MX
Mexico
Prior art keywords
vitamina
dihidro
cia
trans
derivatives
Prior art date
Application number
MX775774U
Other languages
English (en)
Inventor
Derek Harold Richard Barton
Robert Henry Hesse
Original Assignee
Res Inst Medicine Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Inst Medicine Chem filed Critical Res Inst Medicine Chem
Publication of MX4820E publication Critical patent/MX4820E/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/24All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MX775774U 1976-06-03 1977-06-02 Procedimiento para la preparacion de derivados de 5,6-cia y-5,6-trans-10,19-dihidro vitamina d MX4820E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB23036/76A GB1583749A (en) 1976-06-03 1976-06-03 Vitamin d derivatives

Publications (1)

Publication Number Publication Date
MX4820E true MX4820E (es) 1982-10-20

Family

ID=10189072

Family Applications (1)

Application Number Title Priority Date Filing Date
MX775774U MX4820E (es) 1976-06-03 1977-06-02 Procedimiento para la preparacion de derivados de 5,6-cia y-5,6-trans-10,19-dihidro vitamina d

Country Status (21)

Country Link
US (1) US4159326A (es)
JP (1) JPS5315356A (es)
AU (1) AU517020B2 (es)
BE (1) BE855326A (es)
CA (1) CA1111435A (es)
CH (1) CH629768A5 (es)
DE (1) DE2724994A1 (es)
DK (1) DK243477A (es)
ES (1) ES459413A1 (es)
FR (2) FR2353529A1 (es)
GB (1) GB1583749A (es)
IE (1) IE45627B1 (es)
IL (1) IL52227A (es)
IN (1) IN156431B (es)
LU (1) LU77468A1 (es)
MX (1) MX4820E (es)
NL (1) NL7706056A (es)
NO (1) NO771946L (es)
NZ (1) NZ184288A (es)
SE (1) SE7706469L (es)
ZA (1) ZA773308B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
US6251883B1 (en) 1991-01-08 2001-06-26 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
WO1992012165A1 (en) 1991-01-08 1992-07-23 Lunar Corporation METHODS FOR PREPARATION AND USE OF 1α,24-DIHYDROXY VITAMIN D¿2?
US5789397A (en) * 1991-01-08 1998-08-04 Bone Care International, Inc. Methods for preparation and use of 1A,24(S)-dihydroxy vitamin D2
US6166000A (en) * 1991-01-08 2000-12-26 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-Dihydroxy vitamin . D.sub2
AU4841193A (en) * 1992-08-28 1994-03-29 Lunar Corporation 1alpha,24(S)-dihydroxy vitamin D2, its formation and use
DE69431662T2 (de) * 1993-09-03 2003-09-18 Smithkline Beecham Corp Stabilisierte tablettenformulierung
DE29506819U1 (de) * 1995-04-28 1995-07-13 Zimmermann Jos Gmbh & Co Kg Barre mit Modulen für Tuftingwerkzeuge (II)
US6362350B1 (en) 1999-07-01 2002-03-26 Wisconsin Alumni Research Foundation Crystalline 1α, 24(S)-dihydroxyvitamin D2 and method of purification thereof
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3049553A (en) * 1962-08-14 Process for the production of the reduc-
US2942009A (en) * 1956-02-14 1960-06-21 Philips Corp Method of reducing unsaturated compounds with an alkaline or alkalineearth metal in liquid ammonia
US3607888A (en) * 1969-08-07 1971-09-21 Wisconsin Alumni Res Found 25-hydroxytachysterol3 25-hydroxydihydrotachysterol3 and methods for preparing same
US3725489A (en) * 1969-10-02 1973-04-03 Allied Chem Hydrogenation of alkenes employing an organometallic hydrogenation catalyst
US3697559A (en) * 1971-02-25 1972-10-10 Wisconsin Alumni Res Found 1,25-dihydroxycholecalciferol
US3901928A (en) * 1973-01-10 1975-08-26 Robert Henry Hesse 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds
JPS5119752A (en) * 1974-08-07 1976-02-17 Masayuki Ishikawa 1 arufua* 2 arufuaa jihidorokishikorekarushifuerooruno seiho

Also Published As

Publication number Publication date
SE7706469L (sv) 1977-12-04
NZ184288A (en) 1980-08-26
IL52227A0 (en) 1977-08-31
ZA773308B (en) 1978-07-26
ES459413A1 (es) 1978-04-01
US4159326A (en) 1979-06-26
DE2724994A1 (de) 1977-12-15
DK243477A (da) 1977-12-04
FR2429783B1 (es) 1981-05-08
FR2353529A1 (fr) 1977-12-30
JPS5315356A (en) 1978-02-13
AU2574977A (en) 1978-12-07
CH629768A5 (de) 1982-05-14
NO771946L (no) 1977-12-06
JPS625903B2 (es) 1987-02-07
FR2353529B1 (es) 1980-04-25
IN156431B (es) 1985-08-03
AU517020B2 (en) 1981-07-02
GB1583749A (en) 1981-02-04
BE855326A (fr) 1977-12-02
FR2429783A1 (fr) 1980-01-25
IE45627B1 (en) 1982-10-20
LU77468A1 (es) 1977-09-19
IL52227A (en) 1981-05-20
NL7706056A (nl) 1977-12-06
IE45627L (en) 1977-12-03
CA1111435A (en) 1981-10-27

Similar Documents

Publication Publication Date Title
AR215000A1 (es) Procedimiento para la preparacion de c-076
AR222007A1 (es) Procedimiento para la preparacion de nuevos hentriacontapeptidos
AR220004A1 (es) Procedimiento para la preparacion de derivados de 4,4-dimetil-2-imidazolidinona
AR224095A1 (es) Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3
AR220683A1 (es) Procedimiento para la preparacion de m-fenoxibenzaldehido
AR211887A1 (es) Procedimiento para la preparacion de derivados de endolizina
AR215875A1 (es) Procedimiento para la prepararacion de meta-fenoxi-benzaldehido
AR220684A1 (es) Metodo para la preparacion de 1-fenil-3-azabiciclo(3.1.0)hexanos
AR216937A1 (es) Procedimiento para la preparacion de 1,1,1,2-tetrafluoretano
MX4820E (es) Procedimiento para la preparacion de derivados de 5,6-cia y-5,6-trans-10,19-dihidro vitamina d
MX4972E (es) Procedimiento mejorado para la preparacion de 7 beta-oxiimmino-acilcefalosporinas
MX4664E (es) Procedimiento mejorado para la preparacion de derivados de n-fosfonometilglicina
AR220675A1 (es) Procedimiento para la preparacion de derivados sustituidos de pirido(1,2-a)pirimidinas
AR224110A1 (es) Procedimiento para la preparacion de derivados de 5(6)-benzimidazoles
MX5256E (es) Procedimiento para la preparacion de derivados de 20,21-dinoreburnamenina
MX4796E (es) Procedimiento para la preparacion de derivados de 2-iminotiazolina
AR215634A1 (es) Procedimiento para la preparacion de derivados de psoraleno
MX4649E (es) Procedimiento para la preparacion de n-cicloalquilmetil-2-fenilaminoimidazolinas-(2)-substituidas
ES497530A0 (es) Procedimiento para la preparacion de derivados de 2,3-indo- lediona
MX4593E (es) Procedimiento para la preparacion de derivados de isobutiramida
AR217664A1 (es) Procedimiento para la preparacion de derivados de oleandomicina
MX4640E (es) Procedimiento mejorado para la preparacion de derivados de xanteno
ES501213A0 (es) Procedimiento para la preparacion de derivados de 2,3,4,5- tetrahidro-1-benzoxepin-3,5-diona
MX4750E (es) Procedimiento para la preparacion de gamma-pironas
MX6009E (es) Procedimiento para la preparacion de tetrahidro-1,3,5-tiadiazin-4-onas